DURHAM, N.C., Aug. 18, 2015 /PRNewswire/ -- Schulman Associates IRB, Inc., the industry-leading central IRB in customer service and technology, is pleased to announce its new office in the Research Triangle Park, Durham, North Carolina, is officially open for business.
"We are thrilled to open the doors of our new space in RTP," said Michael Woods, President, CEO and Institutional Official at Schulman. "Since breaking ground in June, we've all anticipated this day and are excited to start working even more closely with our new neighbors in the local life sciences community. Our new office's proximity to many of Schulman's clients will also help us establish relationships and better serve research organizations located in this vibrant research hub."
Located at 10 Laboratory Drive, Schulman's RTP space features state-of-the-art communication technology infrastructure, enabling robust and efficient discussions among Schulman's diverse board membership, whose locations are spread across the continent. The technology hub will also help Schulman staff to communicate rapidly with clients and others within the organization in its unwavering commitment to deliver exceptional customer service.
Schulman's new space also includes two flexible, multi-purpose meeting spaces dedicated to increasing collaboration across the organization and with others in the research community. These spaces each accommodate 20-40 people.
The overall office space plan is designed to be bright, open and energetic, with a floor plan that encourages staff collaboration and teamwork. The office will house review board members, IT, operations and customer service professionals.
An open house is slated for October. More information about the event will be provided in the coming weeks.
About Schulman Associates IRB, Inc.
Schulman Associates IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services – including dedicated review capabilities for all phases of research across all therapeutic areas – to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services through its joint venture partner Provision Research Compliance Services, offering comprehensive solutions to improve overall quality standards for clinical studies and data integrity, and to maximize the protection of human subjects. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).
SOURCE Schulman Associates IRB